COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited, NSE: COHANCE, BSE: 543064) has disclosed that its management will attend two investor conferences in May 2026: Citi's 2026 Pan-Asia Investor Conference (May 18-20, virtual) and B&K's 16th Annual Investor Conference in Mumbai (May 27, 2026). The filing dated May 13, 2026 is made under SEBI Regulation 30 (LODR) and explicitly states that no Unpublished Price Sensitive Information (UPSI) will be shared during these interactions. The schedule may change due to exigencies.
This is a routine regulatory disclosure with no immediate impact on the stock. The company's explicit mention that no UPSI will be shared suggests no major announcements are expected at these meetings. Regular investor engagement is standard practice and signals continued focus on shareholder communication.